The doctors and scientists engaged in a long, and hitherto losing, struggle against the rise in diabetes and obesity around the world got excited this week. Who can blame them for bursting into applause as the promising clinical trial results of treatments to follow Novo Nordisk’s Wegovy drug were unveiled?Not only was there a new injectable formula that helped patients to lose up to 24 per cent of body weight in one trial, but the San Diego conference heard of fast progress towards pills that could work as effectively as the Danish group’s Wegovy and Ozempic. The overweight and obese, or at least those that can afford such pills, now have hope.
全世界許多醫生和科學家對日漸增多的糖尿病和肥胖症進行了一場漫長但迄今依然失敗的鬥爭，上週的一個訊息無疑讓他們感到了振奮。當諾和諾德(Novo Nordisk)生產的Wegovy（司美格魯肽注射液）公佈了看起來大有前景的臨牀試驗結果時，誰能因爲他們爆發出熱烈的掌聲而責怪他們呢？